-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Day One Biopharmaceuticals, Inc. quarterly and annual Amortization of Intangible Assets in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
- Day One Biopharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending 31 Dec 2025 was $785,000, a 38% increase year-over-year.
- Day One Biopharmaceuticals, Inc. Amortization of Intangible Assets for the twelve months ending 31 Dec 2025 was $3,110,000, a 112% increase year-over-year.
- Day One Biopharmaceuticals, Inc. annual Amortization of Intangible Assets for 2025 was $3,110,000, a 112% increase from 2024.
- Day One Biopharmaceuticals, Inc. annual Amortization of Intangible Assets for 2024 was $1,470,000.
- Day One Biopharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $0.